Compare FSP & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSP | BTMD |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 72.7M |
| IPO Year | 2001 | 2021 |
| Metric | FSP | BTMD |
|---|---|---|
| Price | $0.50 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.83 |
| AVG Volume (30 Days) | ★ 348.4K | 183.1K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.34% | N/A |
| EPS Growth | 15.69 | ★ 722.22 |
| EPS | N/A | ★ 0.06 |
| Revenue | $107,162,000.00 | ★ $192,219,000.00 |
| Revenue This Year | $17.91 | $2.03 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | $34.50 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $1.27 |
| 52 Week High | $1.84 | $4.75 |
| Indicator | FSP | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.53 | 48.02 |
| Support Level | N/A | $1.35 |
| Resistance Level | $0.70 | $2.79 |
| Average True Range (ATR) | 0.03 | 0.15 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 3.87 | 35.23 |
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.